Vancomycin below the standard level of blood concentration to treat a critically ill child

Vancomycin below the standard level of blood concentration to treat a critically ill child

Bibliographic Details
Main Authors:	Zhuo Li, Baoli Qi, Yuan Yuan, Hua Liu
Format:	Article
Language:	English
Published:	Elsevier 2023-08-01
Series:	Asian Journal of Surgery
Subjects:	Vancomycin Linezolid Blood concentration
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958423003482

Similar Items

Comparative Study of Linezolid and Vancomycin Regimens in One-Stage Surgery for Treating Limb Traumatic Osteomyelitis Caused by Methicillin-Resistant Staphylococcus aureus
by: Zhou Rongchang, et al.
Published: (2023-09-01)

Linezolid and vancomycin for nosocomial infections in pediatric patients: a systematic review
by: Bruno Russo Porchera, et al.
Published: (2024-05-01)

Activity of vancomycin combined with linezolid against clinical vancomycin-resistant Enterococcus strains
by: Gulseren Aktas
Published: (2020-07-01)

Clinical profile and antibiotic susceptibility pattern of Enterococcus faecalis and Enterococcus faecium with an emphasis on vancomycin resistance
by: Mohan Bilikallahalli Sannathimmappa, et al.
Published: (2023-01-01)

Risk factors for mortality after linezolid treatment of vancomycin-resistant Enterococcus bloodstream infection
by: Szu-Ting Huang, et al.
Published: (2023-04-01)

Vancomycin-Resistant Enterococcal Infections: Review of Eight Cases
by: Fatma BAYRAK KENİ, et al.
Published: (2014-12-01)

Successful treatment of Enterococcus gallinarum infection in a neonate with vancomycin: a case report
by: Liangjie Hao, et al.
Published: (2024-08-01)

Analysis of molecular epidemiological characteristics and antimicrobial susceptibility of vancomycin-resistant and linezolid-resistant Enterococcus in China
by: Ping Pan, et al.
Published: (2024-07-01)

Stevens-Johnson Syndrome Following Vancomycin and Linezolid: A Real-World Analysis of Post-Marketing Surveillance Data
by: Ming Ni, et al.
Published: (2022-04-01)

Linezolid for the Treatment of Urinary Tract Infections Caused by Vancomycin-Resistant Enterococci
by: Mary Joyce Wingler, et al.
Published: (2021-10-01)

Effectiveness, safety, and cost of vancomycin and linezolid in Kuwait: A retrospective cohort study
by: Sarah S. Alghanem, et al.
Published: (2023-11-01)

Association between trough serum vancomycin concentration and vancomycin-associated acute kidney injury and 30-day mortality in critically ill elderly adults
by: Jialong Chen, et al.
Published: (2024-03-01)

Effect of First Trough Vancomycin Concentration on the Occurrence of AKI in Critically Ill Patients: A Retrospective Study of the MIMIC-IV Database
by: Longzhu Li, et al.
Published: (2022-04-01)

Fosfomycin Enhances the Inhibition Ability of Linezolid Against Biofilms of Vancomycin-Resistant Enterococcus faecium in vitro
by: Chi J, et al.
Published: (2023-12-01)

Usage of Tazocin/Vancomycin versus Tazocin/ Linezolid in the Treatment of Ventilator-Associated Pneumonia in Traumatized Contused Lungs
by: Mohamed Gaber Ibrahium Mostafa Allam
Published: (2020-08-01)

A Nanoplex PCR Assay for the Simultaneous Detection of Vancomycin- and Linezolid-Resistant Genes in <i>Enterococcus</i>
by: Yusuf Wada, et al.
Published: (2023-02-01)

A real-world cost-effectiveness study of vancomycin versus linezolid for the treatment of late-onset neonatal sepsis in the NICU in China
by: Linjun Xie, et al.
Published: (2023-07-01)

Relationship between nephrotoxicity and area under the concentration–time curve of vancomycin in critically ill patients: a multicenter retrospective study
by: Tomoyuki Ishigo, et al.
Published: (2024-07-01)

Antibiotic choices among healthcare professionals for enterococcal bacteremia with patterns of resistance and risk factors of mortality, in settings of poor antibiotic stewardship program — a five-year retrospective cohort study
by: Jamil Muqtadir Bhatti, et al.
Published: (2023-08-01)

Prevalence of Vancomycin-resistant enterococci (VRE) in Egypt (2010–2022): a systematic review and meta-analysis
by: Ahmed Azzam, et al.
Published: (2023-04-01)

Delayed-Onset Post-Keratoplasty Endophthalmitis Caused by Vancomycin-Resistant Enterococcus faecium
by: Julio C. Hernandez-Camarena, et al.
Published: (2012-10-01)

Real-World Data Study on Risk Factors Associated with Acute Kidney Damage in Patients Treated with Anti-MRSA Antibiotics
by: Ivan Maray, et al.
Published: (2024-01-01)

Enterococci, <i>Van</i> Gene-Carrying Enterococci, and Vancomycin Concentrations in the Influent of a Wastewater Treatment Plant in Southeast Germany
by: Michael Geissler, et al.
Published: (2024-01-01)

The Serum Concentration of Vancomycin as a Diagnostic Predictor of Nephrotoxic Acute Kidney Injury in Critically Ill Patients
by: Welder Zamoner, et al.
Published: (2022-01-01)

Fierce poison to others: the phenomenon of bacterial dependence on antibiotics
by: Claudia C. Paredes-Amaya, et al.
Published: (2023-08-01)

Case analysis of hepatotoxicity caused by vancomycin
by: Jiayao Wu, et al.
Published: (2024-06-01)

Concerning Nephrotoxicity of Top Guns: Concomitant Pippercillintazobactam and Vancomycin with Vancomycin Alone During Treatment of Critically Ill Patients
by: Sadaf Sheikh, et al.
Published: (2020-03-01)

A nomogram incorporating linezolid and metabolite concentrations for predicting linezolid induced thrombocytopenia in patients with renal impairment
by: Hanzhen Zhao, et al.
Published: (2024-10-01)

Factors influencing vancomycin trough concentration in burn patients: a single center retrospective study
by: Yan Shi, et al.
Published: (2024-12-01)

Is It Still Beneficial to Monitor the Trough Concentration of Vancomycin? A Quantitative Meta-Analysis of Nephrotoxicity and Efficacy
by: Wanqiu Yang, et al.
Published: (2024-05-01)

Evaluation of the variability and safety of serum trough concentrations of vancomycin in patients admitted to the intensive care unit
by: Xiaodan Qian, et al.
Published: (2017-07-01)

Revisiting methicillin-resistant <i>Staphylococcus aureus</i> infections
by: Waness Abdelkarim
Published: (2010-01-01)

Population Pharmacokinetics and Dosing Simulation of Vancomycin Administered by Continuous Injection in Critically Ill Patient
by: Romain Garreau, et al.
Published: (2021-10-01)

Clinical Pharmacology of Antimicrobials: Focus on the Safety of Vancomycin and Linezolid
by: M. V. Zhuravleva, et al.
Published: (2023-12-01)

Successful treatment of vancomycin-resistant enterococcus ventriculitis in a child
by: Paulo Sérgio Lucas da Silva, et al.

Enteral Vancomycin to Eliminate MRSA Carriership of the Digestive Tract in Critically Ill Patients
by: Sophie H. Buitinck, et al.
Published: (2022-02-01)

The Development and Validation of a Simple HPLC-UV Method for the Determination of Vancomycin Concentration in Human Plasma and Application in Critically Ill Patients
by: Asma Aboelezz, et al.
Published: (2025-02-01)

Risk factors for vancomycin-resistant enterococci colonisation in critically ill patients
by: Deivid William da Fonseca Batistão, et al.
Published: (2012-02-01)

A Systematic Review on Clinical Safety and Efficacy of Vancomycin Loading Dose in Critically Ill Patients
by: Abdul Haseeb, et al.
Published: (2022-03-01)

Prediction of vancomycin initial dosage using artificial intelligence models applying ensemble strategy
by: Wen-Hsien Ho, et al.
Published: (2023-03-01)